Meccellis Biotech
PrivateLast Round
Series B
Nov 14, 2022
Total Funding Raised
$8.53M
Momentum Score
50 /100
Company Overview
Meccellis Biotech is a medical device company that develops and markets a range of allografts and xenografts for dental, orthopedic, and visceral surgery.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology
Business Model
B2B
Customer Profile
Hardware Sales, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Meccellis Biotech Comps
Public and private peers based on sector, stage, and business model.
Meccellis Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Nov 14, 2022 | ||||
| Seed | Jul 6, 2015 |
Meccellis Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Banque Populaire | Series B |
| Bpifrance | Series B |
| Océan Participations | Series B |
| European Union | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 13, 2026
Monthly visitors grew 40% MoM.
- Apr 19, 2026
Monthly visitors increased 162% MoM, reaching 1K.
Meccellis Biotech Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Meccellis Biotech's valuation, stock price, and market status.